Generic Name and Formulations:
Neisseria meningitidis recombinant proteins 50mcg each of Neisserial adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), and factor H binding protein (fHbp), 25mcg of Outer Membrane Vesicles (OMV); per 0.5mL; susp for IM inj.
Indications for BEXSERO:
Meningitis B immunization.
Adults and Children:
<10yrs: not established. Give by IM inj in deltoid muscle of upper arm. 10–25yrs: 2 doses (0.5mL each) given at least 1 month apart.
Severe allergic reaction after a previous dose of Bexsero.
May not protect against all meningococcal serogroup B strains. Have epinephrine inj available. Immunosuppressed. Latex allergy. Elderly. Pregnancy (Cat.B). Nursing mothers.
Concomitant other vaccines: see full labeling.
Inj site pain, myalgia, erythema, fatigue, headache, induration, nausea, arthralgia; syncope.
To register women who receive Bexsero during pregnancy call (877) 683-4732.
Single-dose prefilled syringes—1, 10
Endocrinology Advisor Articles
- Diet Quality and Glycemic Control in Women With Gestational Diabetes
- Most Foods Containing Fructose Do Not Have Harmful Effect on Glycemic Control
- Effects of a Low-Carbohydrate Diet on Weight Loss Maintenance
- Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D
- Comparative Assessment of Diabetes Outcomes With Physician, NP, PA Providers
- Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D
- Parental Perception of Child Weight Status Predicted by Child BMI z Scores
- Fear Impacts Quality of Life for Young Adults With Type 1 Diabetes
- Five-Year Efficacy Data Announced for Liletta Intrauterine System
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information